Cargando…
Pathways and cost-effectiveness of routine lung cancer inpatient care in rural Anhui, China: a retrospective cohort study protocol
INTRODUCTION: Routine inpatient care (RIC) for patients with cancer forms various pathways of clinical procedures. Although most individual procedures comprising the pathways have been tested via clinical trials, little is known about the collective cost and effectiveness of the pathways as a whole....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879485/ https://www.ncbi.nlm.nih.gov/pubmed/29463588 http://dx.doi.org/10.1136/bmjopen-2017-018519 |
_version_ | 1783311011901603840 |
---|---|
author | Shen, XingRong Diao, MengJie Lu, ManMan Feng, Rui Zhang, PanPan Jiang, Tao Wang, DeBin |
author_facet | Shen, XingRong Diao, MengJie Lu, ManMan Feng, Rui Zhang, PanPan Jiang, Tao Wang, DeBin |
author_sort | Shen, XingRong |
collection | PubMed |
description | INTRODUCTION: Routine inpatient care (RIC) for patients with cancer forms various pathways of clinical procedures. Although most individual procedures comprising the pathways have been tested via clinical trials, little is known about the collective cost and effectiveness of the pathways as a whole. This study aims at exploring RIC pathways for patients with lung cancer from rural Anhui, China, and their determinants and economic impacts. METHODS AND ANALYSIS: The study adopts a retrospective cohort design and proceeds in five steps. Step 1 defines the four main categories of study variables, including clinical procedures, direct cost and effectiveness of procedures, and factors affecting use of these procedures and their cost and effectiveness. Step 2 selects a cohort of 5000 patients with lung cancer diagnosed between 1 July 2015 and 30 June 2016 from rural Anhui by clustered random sampling. Step 3 retrieves the records of all the inpatient care episodes due to lung cancer and extracts data about RIC procedures, proximate variables (eg, Karnofsky Performance Status, Lung Function Score) of patient outcomes and related factors (eg, stage of cancer, age, gender), by two independent clinician researchers using a web-based form. Step 4 estimates the direct cost of each of the RIC procedures using micro-costing and collects data about ultimate patient outcomes (survival and progression-free survival) through a follow-up survey of patients and/or their close relatives. Step 5 analyses the data collected and explores pathways of RIC procedures and their relations with patient outcomes, costs, cost:effect ratios, and a whole range of clinical and sociodemographic factors using multivariate regression and path models. ETHICS AND DISSEMINATION: The study protocol has been approved by an authorised ethics committee of Anhui Medical University (reference number: 20170312). Findings from the study will be disseminated through conventional academic routes such as peer-reviewed publications and presentations at regional, national and international conferences. TRIAL REGISTRATION NUMBER: ISRCTN25595562. |
format | Online Article Text |
id | pubmed-5879485 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-58794852018-04-03 Pathways and cost-effectiveness of routine lung cancer inpatient care in rural Anhui, China: a retrospective cohort study protocol Shen, XingRong Diao, MengJie Lu, ManMan Feng, Rui Zhang, PanPan Jiang, Tao Wang, DeBin BMJ Open Health Economics INTRODUCTION: Routine inpatient care (RIC) for patients with cancer forms various pathways of clinical procedures. Although most individual procedures comprising the pathways have been tested via clinical trials, little is known about the collective cost and effectiveness of the pathways as a whole. This study aims at exploring RIC pathways for patients with lung cancer from rural Anhui, China, and their determinants and economic impacts. METHODS AND ANALYSIS: The study adopts a retrospective cohort design and proceeds in five steps. Step 1 defines the four main categories of study variables, including clinical procedures, direct cost and effectiveness of procedures, and factors affecting use of these procedures and their cost and effectiveness. Step 2 selects a cohort of 5000 patients with lung cancer diagnosed between 1 July 2015 and 30 June 2016 from rural Anhui by clustered random sampling. Step 3 retrieves the records of all the inpatient care episodes due to lung cancer and extracts data about RIC procedures, proximate variables (eg, Karnofsky Performance Status, Lung Function Score) of patient outcomes and related factors (eg, stage of cancer, age, gender), by two independent clinician researchers using a web-based form. Step 4 estimates the direct cost of each of the RIC procedures using micro-costing and collects data about ultimate patient outcomes (survival and progression-free survival) through a follow-up survey of patients and/or their close relatives. Step 5 analyses the data collected and explores pathways of RIC procedures and their relations with patient outcomes, costs, cost:effect ratios, and a whole range of clinical and sociodemographic factors using multivariate regression and path models. ETHICS AND DISSEMINATION: The study protocol has been approved by an authorised ethics committee of Anhui Medical University (reference number: 20170312). Findings from the study will be disseminated through conventional academic routes such as peer-reviewed publications and presentations at regional, national and international conferences. TRIAL REGISTRATION NUMBER: ISRCTN25595562. BMJ Publishing Group 2018-02-20 /pmc/articles/PMC5879485/ /pubmed/29463588 http://dx.doi.org/10.1136/bmjopen-2017-018519 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Health Economics Shen, XingRong Diao, MengJie Lu, ManMan Feng, Rui Zhang, PanPan Jiang, Tao Wang, DeBin Pathways and cost-effectiveness of routine lung cancer inpatient care in rural Anhui, China: a retrospective cohort study protocol |
title | Pathways and cost-effectiveness of routine lung cancer inpatient care in rural Anhui, China: a retrospective cohort study protocol |
title_full | Pathways and cost-effectiveness of routine lung cancer inpatient care in rural Anhui, China: a retrospective cohort study protocol |
title_fullStr | Pathways and cost-effectiveness of routine lung cancer inpatient care in rural Anhui, China: a retrospective cohort study protocol |
title_full_unstemmed | Pathways and cost-effectiveness of routine lung cancer inpatient care in rural Anhui, China: a retrospective cohort study protocol |
title_short | Pathways and cost-effectiveness of routine lung cancer inpatient care in rural Anhui, China: a retrospective cohort study protocol |
title_sort | pathways and cost-effectiveness of routine lung cancer inpatient care in rural anhui, china: a retrospective cohort study protocol |
topic | Health Economics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879485/ https://www.ncbi.nlm.nih.gov/pubmed/29463588 http://dx.doi.org/10.1136/bmjopen-2017-018519 |
work_keys_str_mv | AT shenxingrong pathwaysandcosteffectivenessofroutinelungcancerinpatientcareinruralanhuichinaaretrospectivecohortstudyprotocol AT diaomengjie pathwaysandcosteffectivenessofroutinelungcancerinpatientcareinruralanhuichinaaretrospectivecohortstudyprotocol AT lumanman pathwaysandcosteffectivenessofroutinelungcancerinpatientcareinruralanhuichinaaretrospectivecohortstudyprotocol AT fengrui pathwaysandcosteffectivenessofroutinelungcancerinpatientcareinruralanhuichinaaretrospectivecohortstudyprotocol AT zhangpanpan pathwaysandcosteffectivenessofroutinelungcancerinpatientcareinruralanhuichinaaretrospectivecohortstudyprotocol AT jiangtao pathwaysandcosteffectivenessofroutinelungcancerinpatientcareinruralanhuichinaaretrospectivecohortstudyprotocol AT wangdebin pathwaysandcosteffectivenessofroutinelungcancerinpatientcareinruralanhuichinaaretrospectivecohortstudyprotocol |